Related references
Note: Only part of the references are listed.Magnetization transfer imaging in multiple sclerosis treated with alemtuzumab
Tom Button et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Effects of dimethyl fumarate on neuroprotection and immunomodulation
Philipp Albrecht et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Message from the Editors to our Reviewers
R. A. Gross et al.
NEUROLOGY (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Robert J. Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Fumarates Promote Cytoprotection of Central Nervous System Cells against Oxidative Stress via the Nuclear Factor (Erythroid-Derived 2)-Like 2 Pathway
Robert H. Scannevin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
Ralf A. Linker et al.
BRAIN (2011)
Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis
Maria Pia Sormani et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Measuring Demyelination and Remyelination in Acute Multiple Sclerosis Lesion Voxels
Paul S. Giacomini et al.
ARCHIVES OF NEUROLOGY (2009)
Imaging outcomes for neuroprotection and repair in multiple sclerosis trials
Frederik Barkhof et al.
NATURE REVIEWS NEUROLOGY (2009)
Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions
Jacqueline T. Chen et al.
ANNALS OF NEUROLOGY (2008)
Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion
J. T. Chen et al.
NEUROIMAGE (2007)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Multicontrast MRI of remyelination in the central nervous system
D Merkler et al.
NMR IN BIOMEDICINE (2005)
The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy
Y Gilgun-Sherki et al.
JOURNAL OF NEUROLOGY (2004)
Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain
K Schmierer et al.
ANNALS OF NEUROLOGY (2004)
European study on intravenous immunoglobulin in multiple sclerosis - Results of magnetization transfer magnetic resonance imaging analysis
M Filippi et al.
ARCHIVES OF NEUROLOGY (2004)
Remyelinated lesions in multiple sclerosis -: Magnetic resonance image appearance
F Barkhof et al.
ARCHIVES OF NEUROLOGY (2003)
Evolution of focal and diffuse magnetisation transfer abnormalities in multiple sclerosis
C Laule et al.
JOURNAL OF NEUROLOGY (2003)
Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance
David H. Miller et al.
BRAIN (2002)
Magnetization transfer in MRI: a review
RM Henkelman et al.
NMR IN BIOMEDICINE (2001)
Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis
ND Richert et al.
MULTIPLE SCLEROSIS (2001)
In vivo evaluation of remyelination in rat brain by magnetization transfer imaging
MSA Deloire-Grassin et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2000)
Share Paper
